Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine
Clinical trial NCT03303105 · COMPLETED
Trial details
- NCT number
- NCT03303105
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-07
- Primary completion
- 2020-06-16
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.